🔎 Trials Near Me

Utama › Sklerosis Pelbagai › Illinois › Chicago

Kajian klinikal Sklerosis Pelbagai di Chicago, IL

15 kajian untuk Sklerosis Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Mengambil pesertaKajian pemerhatian
  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Mengambil pesertaFasa 2
  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Mengambil pesertaFasa 3
  • University of Chicago Medical Center, Chicago
Umur 10 hingga 17 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06408259

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

Mengambil peserta
  • Shirley Ryan AbilityLab, Chicago
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07132775

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Mengambil pesertaFasa 3
  • Northwestern Memorial Hospital, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07225504

Ocrevus Zunovo for MS: Mixed Methods

Mengambil pesertaKajian pemerhatian
  • Northwestern Memorial Hospital, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Jul 2026 · NCT07710105

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

Mengambil peserta
  • University of Illinois at Chicago, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT06410261

Functional Balance Intervention in Multiple Sclerosis

Mengambil peserta
  • University of Illinois at Chicago, Chicago
Umur 18 hingga 90 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06341023

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Mengambil peserta
  • University of Illinois at Chicago, Chicago
Umur 18 hingga 64 · Semua jantina · Dikemas kini 4 Jun 2026 · NCT05051618

Nomad P-KAFO Study

Mengambil peserta
  • Shirley Ryan AbilityLab, Chicago
Umur 18 hingga 89 · Semua jantina · Dikemas kini 11 Mei 2026 · NCT05644522

Intermittent Hypoxia in Persons With Multiple Sclerosis

Mengambil peserta
  • Shirley Ryan AbilityLab, Chicago
Umur 18 hingga 75 · Semua jantina · Dikemas kini 20 Mac 2026 · NCT06276634

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Mengambil pesertaKajian pemerhatian
  • Northwestern Memorial Hospital, Chicago
Umur 18 hingga 70 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT07207148

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Mengambil pesertaFasa 4
  • Northwestern Memorial Hospital, Chicago
Umur 18 hingga 70 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT07225361

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Mengambil peserta
  • Shirley Ryan AbilityLab, Chicago
Umur 18 hingga 75 · Semua jantina · Dikemas kini 23 Feb 2026 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

Mengambil peserta
  • University of Illinois at Chicago, Chicago
Umur 40 hingga 90 · Semua jantina · Dikemas kini 21 Jan 2026 · NCT07355387

Kajian Sklerosis Pelbagai di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.